Skip to main content

and
  1. No Access

    Article

    Carboplatin plus weekly docetaxel as salvage chemotherapy in docetaxel-resistant and castration-resistant prostate cancer

    There is no proven, effective, standard second-line chemotherapy for castration- and docetaxel-resistant prostate cancer (DRPC). Recent data suggest that carboplatin may be effective in combination with doceta...

    Christoph W. M. Reuter, Michael A. Morgan, Philipp Ivanyi in World Journal of Urology (2010)

  2. No Access

    Article

    Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma

    Metastatic renal cell carcinoma (RCC) is resistant to conventional chemotherapy. Combined data for a variety of immunotherapies resulted in an overall chance of partial (PR) or complete remission (CR) of only ...

    Christoph W. M. Reuter, Michael A. Morgan, Viktor Grünwald in World Journal of Urology (2007)